Aldurazyme and Infusion site erythema - a phase IV clinical study of FDA data
Summary:
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Aldurazyme?
Aldurazyme has active ingredients of laronidase. Currently, eHealthMe is studying from 4,212 Aldurazyme users.
What is Infusion Site Erythema?
Infusion site erythema (reddening of the skin at infusion site) is found to be associated with 930 drugs and 376 conditions by eHealthMe. Currently, we are studying 5,859 people who have Infusion site erythema.
Do you take Aldurazyme and have Infusion site erythema?
Check whether Infusion site erythema is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Aldurazyme side effects by duration, gender and age:
- Aldurazyme side effects (4,212 reports)
Infusion site erythema treatments and more:
- Infusion site erythema (5,859 reports)
All the drugs that are associated with Infusion site erythema:
All the conditions that are associated with Infusion site erythema:
How the study uses the data?
The study uses data from the FDA. It is based on laronidase (the active ingredients of Aldurazyme) and Aldurazyme (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Aredia and Protein Urine - 37 seconds ago
- Imodium A-D and Amoxicillin drug interaction - a minute ago
- Vagifem and Klonopin drug interaction - a minute ago
- Citalopram Hydrobromide and Fever - 2 minutes ago
- Telmisartan and Albuterol drug interaction - 2 minutes ago
- Centrum and Xgeva drug interaction - 2 minutes ago
- Temazepam and Chlorpheniramine Maleate drug interaction - 3 minutes ago
- Varenicline Tartrate and Tylenol W/ Codeine drug interaction - 4 minutes ago
- Mirtazapine and Simbrinza drug interaction - 4 minutes ago
- Lamotrigine and Oxcarbazepine drug interaction - 4 minutes ago